City

Shanghai (1)

Condition

Advanced Liver Cancers (2)

Advanced Pancreatic Cancers (1)

Effects of Immunotherapy (1)

Treatment Side Effects (1)

Tumor Infiltrating Lymphocyte (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

Sponsor

National Taiwan University Hospital (1)

Shanghai Juncell Therapeutics (1)

Collaborator

Shanghai 10th People's Hospital (1)

Intervention

dc-cik (1)

tumor infiltrating lymphocyte (1)

Study Documents

Intervention Type

biological (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

advanced liver cancers

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Liver Cancers, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting

Advanced Liver Cancers
+4 more

Tumor Infiltrating Lymphocyte

Shanghai, Shanghai, China

Shanghai Tenth People's Hospital

Dec 19, 2022

Advanced Liver Cancers Trial (DC-CIK)

Not yet recruiting

Advanced Liver Cancers

DC-CIK

(no location specified)

Nov 11, 2022